Individualized Treatment Patterns for Patients with Narcolepsy Treated with Oxybate: A Clinical Practice Perspective.

"Disclosure AR has received consultancy fees from Jazz Pharmaceuticals and Harmony Biosciences. DI is an employee of Stratevi, a consulting firm that has received research funding from Jazz Pharmaceuticals to conduct this study. SM and JP are former employees of Jazz Pharmaceuticals who, in the course of their employment, received stock options exercisable for, and other stock awards of, ordinary shares of Jazz Pharmaceuticals plc. SC is a current employee of Jazz Pharmaceuticals who, in the course of his employment, has received stock options exercisable for, and other stock awards of, ordinary shares of Jazz Pharmaceuticals plc. CB has received consultancy fees from Jazz Pharmaceuticals. The authors report no other conflicts of interest in this work."

"This study was sponsored by Jazz Pharmaceuticals."